Company / EPS (Diluted)
ANAPTYSBIO, INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$6.08
FY2025
5-year range
-$6.08 / -$0.73
FY2021-FY2025
Trend
-33.0%
vs FY2024
Sector context
#187 of 204
Health Care
What the data says
Among 204 Health Care companies, ANAPTYSBIO, INC is in the bottom 8% for eps (diluted). EPS (Diluted) has declined for 3 consecutive years, from $-0.73 in FY2022 to $-6.08 in FY2025.
Based on SEC 10-K filings.
-6.08 in FY2025.
Declined from $-2.11 to $-6.08 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 204This company -$6.08 Sector average -$0.89
▼
-586.1% below sector average
Key checks
Key Insights
- ANAPTYSBIO, INC's eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 33.0% year-over-year.
- Ranks #187 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.08 | -33.0% |
| FY2024 | -$4.57 | -116.6% |
| FY2023 | -$2.11 | -189.0% |
| FY2022 | -$0.73 | +79.7% |
| FY2021 | -$3.60 | -44.0% |
| FY2020 | -$2.50 | +0.0% |
| FY2019 | -$2.50 | +0.0% |
| FY2018 | -$2.50 | -54.3% |
| FY2017 | -$1.62 | +0.0% |
| FY2016 | -$1.62 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026